🧫
Cerebral blood flow regulation in CD2AP mutant mice
active
experiment
Created: 2026-04-06T12:34:46
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-b259d56c-af9a-48b7-a676-44dc523f88e1
🧫 Experiment Protocol
ValidationAlzheimer's diseaseCD2APmiceproposed
Comprehensive assessment of cerebrovascular function in mice with reduced brain endothelial CD2AP, examining both resting blood flow and neurovascular coupling responses. This experiment used advanced imaging techniques to measure cerebral blood flow dynamics, including baseline perfusion and activity-dependent changes. The study also assessed mural cell (pericyte/smooth muscle cell) activity and examined sex-dependent differences in vascular responses to amyloid-beta peptide exposure.
PRIMARY OUTCOME
altered blood flow regulation and neurovascular coupling defects
EXPECTED OUTCOMES
1. The intervention targeting CD2AP shifts altered blood flow regulation and neurovascular coupling defects in the predicted direction relative to the matched control arm.
2. Secondary disease-relevant readouts in Alzheimer's disease remain directionally concordant with the primary endpoint rather than showing isolated single-assay effects.
3. The effect persists after adjustment for baseline covariates, batch effects, or repeated-measures structure used in the study design.
SUCCESS CRITERIA
- Prespecified primary endpoint (altered blood flow regulation and neurovascular coupling defects) improves versus control with p < 0.05 or an equivalent corrected threshold used by the study.
- The effect size is biologically meaningful and reproduced across technical/biological replicates or the validation subset.
- Safety, data quality, and missingness remain within protocol-defined bounds so the result is interpretable rather than driven by attrition or assay failure.
PROTOCOL
1. Establish mice cohorts for Alzheimer's disease and predefine inclusion, exclusion, and quality-control criteria before intervention. 2. Apply the experimental manipulation described for CD2AP, alongside matched control or comparator arms, and document dose, exposure window, and sample timing in a locked protocol log. 3. Measure altered blood flow regulation and neurovascular coupling defects together with orthogonal secondary readouts such as molecular, imaging, behavioral, or safety endpoints that are appropriate to the title and study design. 4. Use blinded outcome assessment where feasible, prespecified statistical analysis, and replicate the core readout across biological replicates or an independent validation subset. 5. Interpret results against the baseline study rationale: Comprehensive assessment of cerebrovascular function in mice with reduced brain endothelial CD2AP, examining both resting blood flow and neurovascular coupling responses. This experiment used advanced imaging techniques to measure cerebral blood flow dynamics,
LINKED HYPOTHESES
Source: PMID 39892386 ↗
🧫 Experiment Extras
PATHWAY
neurovascular coupling, cerebral blood flow regulation
MARKET PRICE
$0.50
STATUS
proposed
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.